Tonight, I started watching the Oxford Nanopore Technologies London Calling 2024 expert panel on “Building a rapid, targeted, and responsive infectious disease system.”Aaron Pomerantz, the Associate Director of Global Segment Marketing at ONT, helped facilitate the session. Dr. Ines Hassan from the Tony Blair Institute for Global Change started. Hassan helps encourage the development and […]
Tonight, I continued watching the session on the MinION Mk1D. The second speaker of the webinar was James Platt, the Director of Sequencing Platforms with Oxford Nanopore Technologies (ONT). They described the details of the MinION’s history. The Mk1D was rebuilt, including USB-C connectivity, Peltier module temperature control, and LED run status indicators. A comparison of the Mk1B […]
Tonight, I watched Devin M. Drown from the University of Alaska Fairbanks present on “Testing the MinION Mk1D in Alaska.” Drown is an Associate Professor and Faculty Director of the Institute of Arctic Biology Genomics Core. Drown is passionate about training, including doing MinION hackathons. Drown, like me, was excited to test the device. They […]
I continued watching the “Nanopore Sequencing Ultra Rich Data for Cancer Research” webinar. It featured Sayonika Mohanta, the Market Segment Manager for Methylation with Oxford Nanopore Technologies (ONT). Mathilde Fiser from the Curie Institute presentation had the title “Transforming Cancer Care: Redefining Cancer Characterization and Predisposition Insights through Nanopore Sequencing.” Fiser explained that the identification of germline alterations […]
The “Nanopore Sequencing Ultra Rich Data for Cancer Research” webinar featured Sayonika Mohanta, the Market Segment Manager for Methylation with Oxford Nanopore Technologies (ONT). Mohanta began by emphasizing that cancer research requires multimodal approaches. The example they presented was the use of WGS of cell-free or circulating tumor DNA combined with proteomics and methylation. They […]
Tonight, I continued watching a session from the London Calling 2024 Clinical & Biopharma Day. The expert panel’s title was “Precision oncology: driving better outcomes for patients, health systems, and populations.” Olivier Lucas, the Director of Oncology with Oxford Nanopore Technologies (ONT), moderated the discussion. The audience asked the panelists questions about sensitivity and risk determination. William Stanford from […]
Tonight, I started watching a new session from the London Calling 2024 Clinical & Biopharma Day. The expert panel’s title was “Precision oncology: driving better outcomes for patients, health systems, and populations.” Olivier Lucas, the Director of Oncology with Oxford Nanopore Technologies (ONT), moderated the discussion. Four speakers began the session with brief introductions. William […]
London Calling 2024 had a Clinical & Biopharma Day on Friday, May 24, 2024. There was an expert panel on “Rare diseases reimagined: genomics in early detection and precision therapies” that I started watching tonight. Nabihah Sachedina, the VP of Health Programs with Oxford Nanopore Technologies (ONT) moderated the session. Five speakers were part of […]
It was nice to have a break and good food for Thanksgiving! Tonight, I watched the ORG.one session from the Nanopore Community Meeting 2024 in Boston. The session’s title was “ORG.one—enabling endangered species to bounce back,” which I enjoyed. Dan Fordham, the Director of Strategic Management with ONT and EMEA, was the facilitator of the showcase. The Org.one […]
Tonight, I watched the question and answer session of the Oxford Nanopore Technologies (ONT) webinar on “Unlocking comprehensive genome analyses for large-scale projects.” The panelists were asked about the role of methylation in large-scale genome sequencing projects. They spoke about investigating methylation in rare diseases, which is emerging as an area of interest. Another question […]